INS and metabolic dysfunction-associated steatotic liver disease: Chronic low-grade inflammation in insulin-sensitive tissues, such as the liver and visceral adipose tissue, is central to obesity-associated insulin resistance, glucose intolerance, and NAFLD progression [59,82].